Company Overview and News

 
BN30 reaches record high

2018-10-04 businessnews.com.au
A strong run over the past month from Chris Ellison-led Mineral Resources, oil and gas outfit Woodside Petroleum and Seven Group Holdings has helped push Business News’ index of 30 local stocks to a record high this week.
WOPEF SVNWF WPL WOPEY SVW

 
Government begins search for ABC chairman after 'firestorm' week

2018-09-30 theage.com.au
The government has begun the search for the next ABC chairman, after a "firestorm" week for the public broadcaster that resulted in the resignation of Justin Milne.
WANHY GJV SWM NWS NWSA SVNWF PRT WANHF SVW

 
Government begins search for ABC chairman after 'firestorm' week

2018-09-30 watoday.com.au
The government has begun the search for the next ABC chairman, after a "firestorm" week for the public broadcaster that resulted in the resignation of Justin Milne.
WANHY GJV SWM NWS NWSA SVNWF PRT WANHF SVW

 
Government begins search for ABC chairman after 'firestorm' week

2018-09-30 smh.com.au
The government has begun the search for the next ABC chairman, after a "firestorm" week for the public broadcaster that resulted in the resignation of Justin Milne.
WANHY GJV SWM NWS NWSA SVNWF PRT WANHF SVW

 
Sharks draw up wishlist to help invest development millions

2018-09-16 smh.com.au
Thanks to our latest prime minister, the Cronulla Sharks are probably the best known of any NRL club in the country. But, as the Liberals have shown us (repeatedly), nothing lasts forever.
WANHY GJV SWM NWS NWSA SVNWF WANHF SVW

 
Faith and hope but no charity for AMP's new $17.7m CEO

2018-08-22 theage.com.au
Francesco De Ferrari’s $17.7 million sign-on bonus as AMP’s new chief executive is long way from “collecting dying people off the street” in Calcutta with the late Mother Theresa, but this American-raised Swiss Italian is not your average business executive.
SVNWF SVW

 
Faith and hope but no charity for AMP's new $17.7m CEO

2018-08-22 smh.com.au
Francesco De Ferrari’s $17.7 million sign-on bonus as AMP’s new chief executive is long way from “collecting dying people off the street” in Calcutta with the late Mother Theresa, but this American-raised Swiss Italian is not your average business executive.
SVNWF SVW

 
Kerry Stokes' Seven Group profits soar on back of mining demand

2018-08-22 theage.com.au
Kerry Stokes' industrial services, media and investment conglomerate Seven Group Holdings has lifted its underlying net profit by a hefty 72 per cent to $321.9 million, easily eclipsing analyst expectations.
BPT BEPTF WANHY SWM SVNWF BCHEY WANHF SVW

 
Kerry Stokes' Seven Group profits soar on back of mining demand

2018-08-22 smh.com.au
Kerry Stokes' industrial services, media and investment conglomerate Seven Group Holdings has lifted its underlying net profit by a hefty 72 per cent to $321.9 million, easily eclipsing analyst expectations.
BPT BEPTF WANHY SWM SVNWF BCHEY WANHF SVW

 
Seven Group opens $40m facility to tap into Sydney’s building boom

2018-08-10 theage.com.au
Seven Group Holdings has opened a new WesTrac heavy machinery facility in Western Sydney to support the city’s future infrastructure boom.
SVNWF SVW

 
Seven Group opens $40m facility to tap into Sydney’s building boom

2018-08-10 smh.com.au
Seven Group Holdings has opened a new WesTrac heavy machinery facility in Western Sydney to support the city’s future infrastructure boom.
SVNWF SVW

 
ACCC to take 'very close' look at Nine's takeover of Fairfax

2018-08-02 abc.net.au
Nine Entertainment's proposed takeover of Fairfax Media will be scrutinised by the competition regulator for 12 weeks, during which it will assess the deal's potential impact on media diversity.
WANHY SWM SVNWF WANHF SVW

1
$38bn bonfire: How Telstra's value has sunk under CEO Andy Penn

2018-05-14 theage.com.au
Is it really just three years since Andy Penn took the top job at Telstra? It must seem like much longer for investors who have now torched $38 billion as the competitive advantage of Sol Trujillo’s big spend starts to sputter.
WANHY SWM SVNWF WANHF SVW

1
$38bn bonfire: How Telstra's value has sunk under CEO Andy Penn

2018-05-14 smh.com.au
Is it really just three years since Andy Penn took the top job at Telstra? It must seem like much longer for investors who have now torched $38 billion as the competitive advantage of Sol Trujillo’s big spend starts to sputter.
WANHY SWM SVNWF WANHF SVW

 
Seven upgrades earnings on strong mining sector

2018-05-14 businessnews.com.au
Seven Group Holdings has upgraded its full-year earnings guidance, after the company said it was performing above expectations due to strength in the mining industry and east coast infrastructure activity.
SVNWF SVW

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...